Drug Side Effects
Search
BLADDER TRANSITIONAL CELL CARCINOMA STAGE III
BLADDER TRANSITIONAL CELL CARCINOMA STAGE III
was reported 39 times
BLADDER TRANSITIONAL CELL CARCINOMA STAGE III is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Glinide [EPC]
4
0.0004
1
Stimulant Laxative [EPC]
1
0.0001
2
Antimycobacterial [EPC]
1
0.0000
3
Dipeptidyl Peptidase 4 Inhibitor [EPC]
1
0.0000
4
Programmed Death Receptor-1 Blocking Antibody [EPC]
3
0.0000
5
Alkylating Drug [EPC]
5
0.0000
6
Sulfonylurea [EPC]
2
0.0000
7
Calcineurin Inhibitor Immunosuppressant [EPC]
2
0.0000
8
Angiotensin Converting Enzyme Inhibitor [EPC]
2
0.0000
9
Xanthine Oxidase Inhibitor [EPC]
2
0.0000
10
HMG-CoA Reductase Inhibitor [EPC]
4
0.0000
11
Angiotensin 2 Receptor Blocker [EPC]
3
0.0000
12
Corticosteroid [EPC]
11
0.0000
13
alpha-Adrenergic Blocker [EPC]
1
0.0000
14
Osmotic Laxative [EPC]
2
0.0000
15
Janus Kinase Inhibitor [EPC]
1
0.0000
16
Platelet Aggregation Inhibitor [EPC]
3
0.0000
17
Interferon beta [EPC]
1
0.0000
18
Proton Pump Inhibitor [EPC]
3
0.0000
19
Insulin Analog [EPC]
2
0.0000
20
Loop Diuretic [EPC]
2
0.0000
21
Vitamin D [EPC]
1
0.0000
22
beta-Adrenergic Blocker [EPC]
1
0.0000
23
Vitamin B12 [EPC]
1
0.0000
24
Nonsteroidal Anti-inflammatory Drug [EPC]
4
0.0000
25
Vitamin C [EPC]
1
0.0000
26
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
27
Atypical Antipsychotic [EPC]
1
0.0000
28
Tumor Necrosis Factor Blocker [EPC]
2
0.0000
29
Thalidomide Analog [EPC]
1
0.0000